Nine Masts Capital’s BeOne Medicines Ltd ONC Stock Holding History

Nine Masts Capital’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-16,716	Closed	-$4.64M	–	129
2025 Q1	$4.64M	Buy	+16,716	New	+$3.91M	3.08%	8
2024 Q4	–	Sell	-17,409	Closed	-$4.21M	–	201
2024 Q3	$4.21M	Buy	17,409 +15,709	+924%	+$2.83M	1.89%	13
2024 Q2	$244K	Sell	1,700 -351	-17%	-$54.1K	0.07%	122
2024 Q1	$324K	Sell	2,051 -12,561	-86%	-$2.02M	0.08%	61
2023 Q4	$2.68M	Buy	14,612 +11,535	+375%	+$2.09M	1.99%	13
2023 Q3	$550K	Buy	+3,077	New	+$609K	0.39%	23
2023 Q1	–	Sell	-3,812	Closed	-$852K	–	44
2022 Q4	$852K	Buy	+3,812	New	+$699K	0.27%	29
2022 Q3	–	Sell	-3,469	Closed	-$566K	–	49
2022 Q2	$566K	Buy	+3,469	New	+$542K	0.15%	29
2021 Q4	–	Sell	-2,248	Closed	-$830K	–	46
2021 Q3	$830K	Buy	+2,248	New	+$735K	0.31%	28

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Nine Masts Capital's ONC Position: Q2 2025 in Review

Nine Masts Capital sold out of BeOne Medicines Ltd (ONC) in Q2 2025, closing a stake of 16,716 shares — an estimated $4.64M sold.

Nine Masts Capital first reported a position in ONC in Q3 2021 and held it in 9 quarters. The position peaked at $4.64M in Q1 2025. 244 funds tracked by Wall St. Rank hold ONC as of Q2 2025.

Nine Masts Capital reported no remaining BeOne Medicines Ltd position as of Q2 2025 after selling out during the quarter.
Nine Masts Capital sold 16,716 BeOne Medicines Ltd shares in Q2 2025, an estimated $4.64M.
Nine Masts Capital first reported a position in BeOne Medicines Ltd in Q3 2021 and held it in 9 quarters.
Nine Masts Capital's BeOne Medicines Ltd position peaked at $4.64M in Q1 2025.
244 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2025.

Based on Nine Masts Capital's 13F filing for Q2 2025, filed 13 Aug 2025.